Chemical Filling

High Purity Human Serum Protein rHSA Bilogical Reagents Lyophilized With Saline?

?

?

Quick detail
# # CAS No.: 70024-90-7
# Other Names: rHSA
# Brand Name: Oryzogen
# Model Number: HY100M1
# EINECS No.: 274-272-6
# Storage and Handling: Stored at temperatures 2-8℃ for 24 months
# Endotoxin: Less than 0.25EU/mg
# Place of Origin: Hubei, China (Mainland)


?

Physiological and Biochemical Properties of rHSA and pHSA

- - - -
Char. | pHSA | rHSA |
Amino Acids Sequence | Same | Same |
N-terminus | DAHKSEV | DAHKSEV |
C-terminus | KLVAASQAALGL | KLVAASQAALGL |
Glycosylation | No | No |
Molecular Mass(MALDI) | 66.554KD | 66.550KD |
PI | 4.8 | 4.8 |
Drug Binding | Similar | Similar |
Thermal Stability | M/P 65℃ | M/P 65℃ |
Lipid Conjugation | Identical | Identical |
Crystal Structure | Identical | Identical |
- - - -

?

Description

As the most abundant protein in human plasma, HSA is composed of 585 amino acids. It has a molecular weight of 66.5KD and an isoelectric point of 4.8. HSA is widely used in biochemical experiments, such as being used as a blocking ragent in Western Blotting. Because HSA plays a role in mailly maintaining the osmotic pressure, PH buffer and as carriers and nutritions, the rHSA can also be used as a hapten carrier, a protective reagent, and in protein complementation control in cell culture.In addition, because of the long half-life, stability and carrier funstion, rHSA is a basic reagent in the biotechnology laboratory.



?

Advantages

1.?With years of effort, Healthgen has developed the State-of-the-Art platform called OryzHiExp, having high capacity to express no animal origin proteins and peptides in the rice endosperm cells.

?

2.?The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity.

At present, the production capacity is almost 1000 kg / year.

?

3.?Healthgen recombinant human serum albumin (rHSA) has excellent batch consistency. Using self-pollination rice as the bioreactor to express the rHSA, with the world& acute;s advanced facility and top production proceeding to extract and purify the rHSA, Healthgen can ensure the excellent consistency of rHSA from different batches.

?

4.?The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity.

At present, the production capacity is almost 1000 kg / year.

?

5.?Healthgen has a professional quality control department, in which 50% of them have master& acute;s degree or higher. There are 14 employees in the quality department, 9 of them are in QA and 5 are in QA. All of them have rich experience in analysis research or quality inspection. Half of them have graduated diploma. Every year there are more than 50 training courses, which cover GMP, SOP, specification, hygiene, QA, QC issues, etc.

We strictly control the quality of our products to ensure that all products into the market will be in line with quality standards.

Healthgen has a series of instruments, which are listed as below.

- - - -
Equipment | Origin |
Microplate reader | Bio-Tek |
Osmotic pressure detector | Tianjin SMC30C-1 |
Liquid Chromatograph | Agilent |
Gas Chromatograph | PE |
Kjeldahl apparatus | Jinan K9840 |
RT-PCR | ABI |
Karl fischer moisture meter | Mettler Toledo |
Atomic absorption instrument | PE |
- - - -
?
Supplemental Description

Healthgen Biotech, always pay great attention to the original technological innovation and intellectual property protection, has the titles of “Hubei Province Molecular Pharmaceutical Engineering Research Center” and “Protein Purification Research Center”. The rice endosperm cell high expression technology platform and other core technology have applied and gained 13 domestic and international patents; and won the “2012 Hubei Provincial Science and technology invention Award”, “2013 National Science and Technology Invention Award and China Patent Excellence Award’. The project obtained the funding from the National Ministry of science and high technology “863 plan”, Major national science and technology plan “Major projects of new varieties of genetically modified organisms” and “Major projects for new drug discovery”, the National Development and Reform Commission “Pilot development of strategic emerging industries”, National Ministry of science and technology innovation fund and state and local plans for all kinds of talented people funding. In July 2015, Healthgen Biotech became a public company on the & quot;China New OTCBB& quot;, a national share transfer system for SMEs and officially known as the National Equities Exchange and Quotations, which is the “first stock” of the plant-derived pharmaceutical in China and even the world.